1. Home
  2. FCF vs NVCR Comparison

FCF vs NVCR Comparison

Compare FCF & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Commonwealth Financial Corporation

FCF

First Commonwealth Financial Corporation

HOLD

Current Price

$20.94

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$15.84

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCF
NVCR
Founded
1934
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
FCF
NVCR
Price
$20.94
$15.84
Analyst Decision
Buy
Buy
Analyst Count
4
6
Target Price
$19.75
★ $28.08
AVG Volume (30 Days)
806.8K
★ 922.2K
Earning Date
04-28-2026
04-30-2026
Dividend Yield
★ 2.94%
N/A
EPS Growth
5.76
★ 21.79
EPS
★ 0.81
N/A
Revenue
N/A
★ $655,353,000.00
Revenue This Year
$16.32
$7.72
Revenue Next Year
$6.25
$6.74
P/E Ratio
$25.85
★ N/A
Revenue Growth
N/A
★ 8.28
52 Week Low
$15.00
$9.82
52 Week High
$22.34
$21.45

Technical Indicators

Market Signals
Indicator
FCF
NVCR
Relative Strength Index (RSI) 48.98 42.57
Support Level $20.45 $14.93
Resistance Level $21.52 $18.43
Average True Range (ATR) 0.34 0.70
MACD -0.03 -0.05
Stochastic Oscillator 38.73 30.84

Price Performance

Historical Comparison
FCF
NVCR

About FCF First Commonwealth Financial Corporation

First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: